SAMN30223180
External Id
dbGaP
INSDC center name
2022-08-10T02:53:16.293Z
INSDC first public
2022-09-22T02:57:15.860Z
INSDC last update
SRS15029603
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS15029603
SRA accession
DNA
analyte type
NCI_LA_HNSCC_Everolimus
biospecimen repository
09266_046_9_T_000018DD7L
biospecimen repository sample id
HYPOPHARYNX
body site
phs002986
gap_accession
1
gap_consent_code
GRU
gap_consent_short_name
5064327
gap_sample_id
4298157
gap_subject_id
Yes
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
male
sex
Case Set
study design
Squamous Cell Carcinoma of Head and Neck
study disease
A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck
study name
Yes
subject is affected
09266_046_9_T_000018DD7L
submitted sample id
046
submitted subject id
NCI_LA_HNSCC_Everolimus
submitter handle
Squamous Cell Carcinoma of Head and Neck tumor DNA sample from HYPOPHARYNX of a human male participant in the dbGaP study A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck
title